GB1246727A - Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids - Google Patents

Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids

Info

Publication number
GB1246727A
GB1246727A GB699769A GB699769A GB1246727A GB 1246727 A GB1246727 A GB 1246727A GB 699769 A GB699769 A GB 699769A GB 699769 A GB699769 A GB 699769A GB 1246727 A GB1246727 A GB 1246727A
Authority
GB
United Kingdom
Prior art keywords
compositions
therapeutic
pharmaceutically acceptable
acids
picolinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB699769A
Other languages
English (en)
Inventor
Hamao Umezawa
Toshiharu Nagatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to GB699769A priority Critical patent/GB1246727A/en
Priority to FR6940314A priority patent/FR2030389B1/fr
Priority to NL6918507A priority patent/NL6918507A/xx
Priority to BE743076D priority patent/BE743076A/xx
Priority to DE19702005255 priority patent/DE2005255C3/de
Publication of GB1246727A publication Critical patent/GB1246727A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB699769A 1969-02-10 1969-02-10 Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids Expired GB1246727A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB699769A GB1246727A (en) 1969-02-10 1969-02-10 Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
FR6940314A FR2030389B1 (xx) 1969-02-10 1969-11-24
NL6918507A NL6918507A (xx) 1969-02-10 1969-12-10
BE743076D BE743076A (xx) 1969-02-10 1969-12-12
DE19702005255 DE2005255C3 (de) 1969-02-10 1970-02-05 Verwendung von Ca-5-butylpicolinat und/oder Ca-5-pentylpicolinat zur Herstellung eines blutdrucksenkenden Arzneimittels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB699769A GB1246727A (en) 1969-02-10 1969-02-10 Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids

Publications (1)

Publication Number Publication Date
GB1246727A true GB1246727A (en) 1971-09-15

Family

ID=9824661

Family Applications (1)

Application Number Title Priority Date Filing Date
GB699769A Expired GB1246727A (en) 1969-02-10 1969-02-10 Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids

Country Status (5)

Country Link
BE (1) BE743076A (xx)
DE (1) DE2005255C3 (xx)
FR (1) FR2030389B1 (xx)
GB (1) GB1246727A (xx)
NL (1) NL6918507A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108847A1 (en) * 1970-10-06 1972-05-26 Zaidan Hojin Biseibutsu 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
FR2132601A1 (en) * 1971-04-07 1972-11-24 Microbial Chem Res Found Anti-alcoholic compsns contng calcium 5-buty

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157368A (en) * 1916-09-15 1922-04-10 Victor Kaplan Improvements in rotor wheels for water turbines with wing-like blades

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors

Also Published As

Publication number Publication date
FR2030389A1 (xx) 1970-11-13
NL6918507A (xx) 1970-08-12
DE2005255C3 (de) 1981-05-14
DE2005255B2 (de) 1980-06-26
FR2030389B1 (xx) 1973-06-08
DE2005255A1 (de) 1970-09-03
BE743076A (xx) 1970-05-14

Similar Documents

Publication Publication Date Title
IL74707A (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
GB1418208A (en) Pharmaceutical compositions
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
ES8502076A1 (es) Procedimiento para la preparacion de acido 3b-(3-carboxipropioniloxi)-ursa-9(11),12-dien-28-oico
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1424611A (en) Pharmaceutical compositions
IE36780B1 (en) New pharmaceutical preparations
GB1375806A (xx)
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
ES8502439A1 (es) Un metodo de preparar una forma solida, estable y soluble en agua de 3-desazaguanina
IE43848L (en) Pharmaceutical compositions
ES8304925A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
ES8505644A1 (es) Procedimiento de preparar derivados de la s-carboximetilcisteina
GB1386927A (en) Preparations for combatting swine dysentery